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Hepatitis B virus (HBV) X protein (HBx) is a regulatory protein that is required for efficient replication of HBV in its natural host. In this
report, we demonstrate by co-immunoprecipitation experiments that HBx can physically bind to the androgen receptor (AR), which is a nuclear
hormone receptor that is expressed in many different tissues including the liver. This observation is further supported by confocal microscopy,
which reveals that HBx can alter the subcellular localization of the AR both in the presence and in the absence of dihydrotestosterone (DHT).
Further studies indicate that HBx can enhance the gene transactivation activity of AR by enhancing its DNA binding activity in a DHT-dependent
manner. However, HBx does not remain associated with AR on the DNA. As AR can regulate the expression of a number of cellular genes, our
results raise the possibility that HBV pathogenesis may be mediated in part via the interaction between HBx and AR.
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Hepatitis B virus (HBV) is an important human pathogen
that can cause severe liver diseases including hepatocellular
carcinoma (HCC). This virus has a small DNA genome that
contains four genes: the S gene encodes the viral envelope
proteins; the C gene encodes the viral core protein and a serum e
antigen; the P gene encodes the viral DNA polymerase; and the
X gene encodes a 16.5-kDa regulatory protein with multiple
functions.
The HBV X protein (HBx) does not bind to DNA directly
(Yen, 1996). However, it can bind to transcription factors
including CREB, ATF-2, AP-2 and HNF1 to modify their
activities (Li et al., 2002; Maguire et al., 1991; Seto et al., 1990;
Williams and Andrisani, 1995). It can also bind to RBP5, a⁎ Corresponding author. Fax: +1 323 442 1721.
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et al., 1995), to the proteasome (Fischer et al., 1995; Hu et al.,
2006), p53 (Wang et al., 1994), a component of the DNA repair
complex UV-DDB (Becker et al., 1998), and a member of the
human voltage-dependent ion channel family HVDAC3
(Rahmani et al., 2000). HBx can also stimulate cellular calcium
signaling pathways, resulting in the activation of focal adhesion
kinase (FAK), prolin-rich tyrosine kinase 2 (Pyk2) and Src, and
the downstream mitogen-activated protein kinase (MAPK)
signaling pathway and the cyclin A–cdk2 complex (Bouchard
et al., 2001, 2006; Klein and Schneider, 1997). HBx can also
activate NFκB (Su et al., 2001). Studies on the related
woodchuck hepatitis B virus (WHV) indicate that the X gene
is required for efficient replication of WHV in woodchucks
(Chen et al., 1993; Zhang et al., 2001; Zoulim et al., 1994).
Further studies using transgenic mice carrying the entire HBV
genome demonstrate that HBx can enhance HBV gene
expression and the subsequent viral DNA replication (Xu et
al., 2002).
Fig. 1. Co-immunoprecipitation of HBx and AR. Huh7 cells were co-transfected
with HA-tagged HBx expression plasmid (pCMV-HAX), AR expression
plasmid (pSG5-AR) and their control vectors in different combinations as
indicated under the gels. (A) Cell lysates were immunoprecipitated using the
anti-HA antibody andWestern blotted using the anti-AR antibody. Lanes 1 and 2
were total cell lysates prior to immunoprecipitation. Cells in lane 1 were
transfected with pRc/CMV and pSG5 control vectors whereas cells in lane 2
were transfected with pCMV-HAX and pSG5-AR. The arrow denotes the AR
protein band and the arrowhead denotes a non-specific protein band, which
served as an internal loading control. (B) Cell lysates were immunoprecipitated
using the anti-AR antibody and Western blotted using the anti-HA antibody.
Lanes 5 and 6 were total cell lysates. Cells in lane 5 were transfected only with
the control vectors whereas cells in lane 6 were transfected with both HAX and
AR expression plasmids. The arrow denotes the HA-tagged HBx (HAX) protein
band.
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a possible role of androgen and/or its receptor in HBV
pathogenesis. Androgen receptor (AR) is a member of the nuclear
receptor superfamily. This protein is approximately 110 kDa in
size. It contains several functional domains including the ligand
binding domain, the DNA binding domain, the transcription
modulation domain and a nuclear localization signal (Lee and
Chang, 2003). After binding to its ligand testosterone or 5α-
dihydrotestosterone (DHT), AR is activated and transported into
the nucleus where it binds to the promoters of its target genes to
activate their expression (Lee and Chang, 2003). AR is expressed
in many different tissues including the liver and has a wide range
of activities. In the liver, it can upregulate the expression of
transforming growth factor β1 (TGF-β1), sex-limited protein (Slp)
and various drug- and steroid-metabolizing enzymes including
specific cytochrome P450 isozymes (Chatterjee et al., 1996; Yoon
et al., 2006). AR is believed to play an important role in
hepatocellular carcinogenesis, as there is an increased risk for
hepatocellular carcinoma (HCC) in patients treated with androgens
(Touraine et al., 1993), and a positive correlation between the HCC
risk and the serum testosterone level (Tanaka et al., 2000; Yu et al.,
2000, 2001). Furthermore, a lower number of the CAG
trinucleotide repeats in exon 1 of the AR gene, which increases
the gene transactivation activity of AR (Beilin et al., 2000;
Chamberlain et al., 1994; Irvine et al., 2000), is also associated
with an increased risk for HCC (Yu et al., 2000, 2001).
In this report, we have investigated the possible interaction
between the HBV regulatory protein HBx and AR. Our results
indicated that HBx could bind to and enhance the gene
transactivation activities of AR in the presence of DHT. This
enhancement of the AR activity by HBV in a DHT-dependent
manner may explain the gender difference of HCC incidence
among HBV carriers.
Results
Co-immunoprecipitation of HBx and AR
To investigate whether HBx and AR can bind to each other,
we performed the co-immunoprecipitation experiments. Huh7
cells, which are human hepatoma cells that do not express
androgen receptor (Xie et al., 2001), were co-transfected with
the AR expression plasmid and the expression plasmid for HA-
tagged HBx. Cells were lysed 48 h after transfection and
immunoprecipitated with the anti-HA antibody, followed by
the Western blot analysis using the anti-AR antibody. As
shown in Fig. 1A, AR could be immunoprecipitated by the
anti-HA antibody in the presence of HA-tagged HBx (lane 6)
but not in the absence of it (lane 5). This result indicated that
AR and HBx could physically bind to each other. This result
was confirmed by a reciprocal experiment, in which the cell
lysates were first immunoprecipitated with the anti-AR anti-
body followed by the Western blot analysis using the anti-HA
antibody. As shown in Fig. 1B, the HA-tagged protein could
be immunoprecipitated by the anti-AR antibody only in the
presence of AR (lane 4) and not in the absence of it (lane 2),
confirming that HBx and AR could bind to each other.Co-localization of HBx and AR in cells
To further investigate how HBx and AR may interact with
each other in the cell, we also performed the confocalmicroscopy.
Huh7 cells were first transfected with either the HA-tagged HBx
expression plasmid or the AR expression plasmid. As shown in
Fig. 2A, HBx displayed a predominantly cytoplasmic localiza-
tion whether or not the cells were treated with dihydrotestoster-
one (DHT) (panels a and b). The staining pattern of HBx in the
cytoplasm was granular, which is consistent with the previous
report (Rahmani et al., 2000). In contrast, AR displayed a more
diffuse cytoplasmic localization in the absence of DHT (panel c).
In agreement with the previous report (Tomura et al., 2001), AR
was localized predominantly to the nucleus after cells were
treated with DHT (panel d).
If HBx and AR can indeed bind to each other in the cell, they
will likely have similar subcellular localizations when they are
co-expressed in the same cell. For this reason, we also co-
transfected Huh7 cells with the HA-tagged HBx expression
plasmid and the AR expression plasmid. As shown in Fig. 2B,
in the absence of DHT, HBx and AR displayed the same
granular cytoplasmic staining pattern (panels a–c), indicating
the co-localization of HBx and AR in the cytoplasm. In the
presence of DHT, most AR was localized to the nucleus.
However, a fraction of AR was also found co-localized with
Fig. 2. Confocal microscopy of the subcellular localization of HBx and AR in Huh7 cells. (A) Subcellular localization of HBx and AR. Panels a and b, cells expressing
HA-tagged HBx; panels c and d, cells expressing AR. Panels a and c, without DHT treatment; panels b and d, with DHT treatment. (B) Co-localization analysis of HBx
and AR. Huh7 cells were co-transfected with the HA-tagged HBx expression plasmid and the AR expression plasmid. Red color, HBx staining; green color, AR
staining; yellow or orange color, co-localization of HBx and AR. Panels a–c, without DHT treatment; and panels d–i, with DHT treatment. The arrow in panels d–f
denotes a cell that co-expressed AR and HBx. The partial colocalization of AR and HBx in the cytoplasm of this cell was clearly visible. Most of HBx and AR double-
positive cells displayed this staining pattern (unpublished observation). The unmarked cell in panels d–f expressed only AR, which was detectable only in the nucleus.
On rare occasions, HBx and AR co-localized in the nucleus (g–i).
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indicating a partial retention of AR in the cytoplasm by HBx.
On rare occasions, HBx was found to co-localize with AR in the
nucleus (panels g–i). These results further indicate the physical
interaction of these two proteins in Huh7 cells.
Enhancement of gene transactivation activity of AR by HBx
To further investigate whether the interaction between HBx
and AR affects the biological activities of AR, we conducted a
gene transactivation assay using the firefly luciferase reporter,
which has been linked to a promoter that contains the androgen
responding element. Huh7 cells were transfected with this re-
porter in the absence or presence of the AR expression plasmid
and the HA-taggedHBx expression plasmid, andwith or without
the DHT treatment. As shown in Fig. 3, this reporter displayedonly basal luciferase activities after its transfection into Huh7
cells, whether the cells were treated with DHT or not. These
results were not surprising, as Huh7 cells do not express
androgen receptor (Xie et al., 2001). The co-transfection of this
reporter with the androgen receptor into Huh7 cells did not
significantly increase the firefly luciferase reporter expression.
However, if the co-transfected cells were treated with DHT for
24 h, the expression of the reporter was increased approximately
300-fold. This result is consistent with the previous observations
that DHT can activate AR (Kang et al., 2002). The inclusion of
the HBx expression plasmid in the co-transfection studies led to
a further 2- to 4-fold increase of the firefly luciferase activities in
a dose-dependent manner. This effect of HBx on the reporter was
observed only in the presence of DHTand not in the absence of it
(data not shown). HBx by itself also had no effect on the
expression of the reporter whether or not Huh7 cells were treated
Fig. 3. Enhancement of gene transactivation activity of AR by HBx. Huh7 cells were transfected with the reporter plasmid Probasin-luc. This plasmid contains the
firefly luciferase reporter, which has been linked to androgen responding elements derived from the rat probasin promoter (Jia et al., 2003). This reporter plasmid was
co-transfected with control vectors or the AR and/or the HBx expression plasmid into Huh7 cells, with or without further DHT treatment as indicated under the chart.
The renila luciferase expression plasmid pRL-SV40 was included in all the transfection studies to monitor the transfection efficiency. Cells were lysed 48 h after
transfection for the dual luciferase assay. The experiments were repeated at least three times and the results shown represent the mean. The relative firefly/renila
luciferase activity of cells transfected with Probasin-luc alone without DHT treatment was arbitrarily defined as one.
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that the effect of HBx on the reporter required DHT and was
mediated by AR.
Enhancement of the DNA binding activity of AR by HBx
To further investigate how HBx enhanced the gene trans-
activation activity of AR, we also conducted the chromatin
immunoprecipitation (ChIP) assay. In this study, Huh7 cells were
transfected with the pMMTV-luciferase reporter plasmid with or
without the AR expression plasmid and the HBx expression
plasmid, and with or without the DHT treatment. The pMMTV-
luciferase contains only one copy of the androgen responding
element and was used in this particular study. After cell lysis, the
AR–DNA complex was immunoprecipitated with the anti-AR
antibody and the DNAwas quantified by the polymerase chain
(PCR) reaction. The PCR results are shown in Fig. 4A and the
quantification results are shown in Fig. 4B. As shown in Fig. 4A,
no reporter DNAwas detected in this ChIP assay if this reporter
was co-transfected with the AR expression plasmid and
immunoprecipitated with a control antibody (lane 2) or if this
reporter was co-transfected with the control pRc/CMV expres-
sion vector and immunoprecipitated with the anti-AR antibody
(lane 3). These two experiments served as the negative controls.
In contrast, a basal level of the reporter DNAwas detected if this
reporter was co-transfected with the AR expression plasmid into
Huh7 cells and immunoprecipitated with the anti-AR antibody
(lane 4). The amount of the reporter DNA precipitated by the
anti-AR antibody was doubled if cells were treated with DHT for
16–18 h (Fig. 4A, lane 5; also Fig. 4B). This increase was further
enhanced by HBx (Fig. 4A, lane 8; also Fig. 4B). HBx had little
effect on the DNA binding activity of AR in the absence of DHT(Fig. 4A, lane 6; also Fig. 4B). Thus, these results indicated that
HBx could enhance the DNA binding activity of AR only in the
presence of DHT.
As HBx could bind to AR, we also investigated whether
HBx remained associated with AR on the reporter DNA. As
HBx was fused to the HA-tag, the anti-HA antibody was used to
immunoprecipitate HBx for the ChIP assay. As shown in Fig. 5,
except for the positive control, almost no reporter DNA could
be detected in this ChIP assay, indicating that HBx did not
remain associated with AR on the reporter DNA.
Discussion
HBx is a regulatory protein with multiple functions. By
conducting the co-immunoprecipitation experiments, we now
demonstrate that HBx can also bind to the steroid hormone
receptor AR (Fig. 1). Our observation was further confirmed by
confocal microscopy. AR had a diffused cytoplasmic localiza-
tion in the absence of DHT (Fig. 2A). However, when it was co-
expressed with HBx, it became co-localized with HBx, which
had a more granular staining pattern in the cytoplasm (Fig. 2B).
AR is translocated into the nucleus after its activation by DHT
(Fig. 2A) (Tomura et al., 2001). In the presence of HBx, it was
partially retained by HBx in the cytoplasm (Fig. 2B). In-
terestingly, HBx was also found on rare occasions to co-localize
with AR in the nucleus (Fig. 2B). It is possible that a small
amount of HBx, which is not detectable by confocal micro-
scopy, is also co-localized with AR in the nucleus in the
presence of DHT.
Upon its activation by DHT, AR is translocated into the
nucleus where it will bind to the androgen responding element
of its target genes to activate their expression (Kang et al., 2002;
Fig. 4. Enhancement of DNA binding activity of AR by HBx. (A) The ChIP
assay. Huh7 cells were co-transfected with DNA plasmids and lysed 48 h after
transfection for the ChIP assay (see Materials and methods for details). Lane M,
DNA molecular weight markers; lane 1, the input DNA control; lane 2, cells co-
transfected with the reporter and pCMV-AR and then immunoprecipitated with a
control antibody; lane 3, cells co-transfected with the reporter and the control
vector pRc/CMV; lane 4, cells co-transfected with the reporter and pCMV-AR;
lane 5, cells co-transfected with the reporter and pCMV-AR and then treated
with DHT on the second day after transfection; lane 6, cells co-transfected with
the reporter, pCMV-AR and pCMV-HAX; and lane 7, cells co-transfected with
the reporter, pCMV-AR and pCMV-HAX and then treated with DHT. In lanes
3–7, the cell lysates were immunoprecipitated with the anti-AR antibody. In
lanes 2–5, the control vector pRc/CMV was used for co-transfection to replace
pCMV-HAX to ensure that the same amount of DNAwas used for transfection.
(B) Quantification of the ChIP assay results. The relative DNA binding activity
of AR was determined by Scion Imaging software. The DNA binding activity of
AR in the absence of HAX and DHT was arbitrarily defined as 1. The results
represent the mean of three independent experiments.
Fig. 5. Association of HBx with AR on the reporter DNA. Huh7 cells were co-
transfected with DNA plasmids of different combinations as shown under the
gel and lysed 48 h after transfection for the ChIP assay (see Materials and
methods for details). Lane M, DNA molecular weight markers; lane 1, cells co-
transfected with the reporter, pCMV-HBx and pCMV-AR and then immuno-
precipitated with a control antibody; lane 2, the input DNA control; lane 3, cells
co-transfected with the reporter and the control vector pRc/CMV; lane 4, cells
co-transfected with the reporter and pCMV-HAX; lane 5, cells co-transfected
with the reporter and pCMV-AR; lane 6, cells co-transfected with the reporter,
pCMV-AR and pCMV-HAX; and lane 7, cells co-transfected with the reporter,
pCMV-AR and pCMV-HAX and then treated with DHT. In lanes 3–7, the cell
lysates were immunoprecipitated with the anti-HA antibody. Except for the
input DNA control (lane 2), no significant amount of the reporter DNA could be
detected in other lanes.
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to detect approximately 300-fold increase of the expression
level of the luciferase reporter after the activation of AR by
DHT. Due to the ability of HBx to bind to AR, we have
investigated whether HBx could affect the gene transactivation
activity of AR. As shown in Fig. 3, HBx could further enhance
the gene transactivation activity of AR 2- to 4-fold in a dose-
dependent manner. This effect of HBx on AR was DHT
dependent, as HBx could not enhance the activity of AR in the
absence of DHT (data not shown).
HBx is not a DNA-binding protein. However, it has been
shown to enhance the DNA binding activity of a number of
transcription factors (Yen, 1996). Our ChIP results shown in Fig.
4 demonstrated that HBx could also enhance the DNA binding
activity of AR. However, as shown in Fig. 5, HBx did not appear
to remain associated with AR on the DNA. This effect of HBx on
AR is reminiscent of its activities on other transcription factors
such as CREB, ATF-2 and HNF1 (Li et al., 2002; Maguire et al.,1991; Williams and Andrisani, 1995). HBx also binds to these
transcription factors to enhance their DNA binding activities, but
it does not remain associated with those transcription factors
after their binding to their target DNA sequences.
It is unclear whether it is the cytoplasmic form or the nuclear
form of HBx that is responsible for the activation of the AR
activity. If it is the cytoplasmic form, then the binding of HBx to
AR may sensitize AR to the activation induced by DHT. This
can explain why HBx enhanced the DNA binding activity of
AR without becoming associated with AR on its target DNA
sequence. It is equally likely that the nuclear form of HBx
activates the AR activity. In this case, however, HBx will
enhance the DNA binding activity of AR after its activation by
DHT, as nuclear transport of AR is DHT dependent.
AR is expressed in many different tissues including the liver
and has a wide range of activities. In the liver, it can upregulate
the expression of many genes including TGF-β1 (Chatterjee
et al., 1996; Yoon et al., 2006) and has been implicated in
hepatocarcinogenesis (Tanaka et al., 2000; Touraine et al., 1993;
Yu et al., 2000, 2001). Our observation that HBx can enhance
the activity of AR in a DHT-dependent manner indicates that
HBx can affect the gene expression profiles in hepatocytes of
male HBV carriers via AR. This effect of HBx is expected to be
lower in the hepatocytes of female HBV carriers due to a lower
level of androgen in women. HCC is male preponderant among
HBV carriers. It is conceivable that this gender difference of
HCC incidence is due in part to the differential effect of HBx on
AR in the hepatocytes of male and female HBV carriers. In this
regard, it is interesting to note that the difference of HCC risks is
much less pronounced between male and female HCV patients
(Chen et al., 2006; Kirk et al., 2004; Lu et al., 2006; Stroffolini
et al., 2006). It is likely that, unlike HBV, HCV does not possess
a factor that can enhance the activity of AR. Further research in
459Y. Zheng et al. / Virology 363 (2007) 454–461this area will likely generate interesting results for under-
standing HBV pathogenesis in different genders.
Materials and methods
Cell lines and DNA plasmids
Huh7 cells were maintained in Dulbecco's modified
essential medium (DMEM) containing 10% fetal bovine
serum (FBS). Depending on the experiments, the FBS might
be treated with dextran-coated charcoal (Sigma-Aldrich) for
the removal of small molecules. pCMV-HAX (Li et al., 2002),
which expresses the HA-tagged HBx under the control of the
immediate early promoter of cytomegalovirus, and pSG5-AR
(Litvinov et al., 2004), which expresses the human androgen
receptor under the SV40 early promoter control, have been
previously described. The expression vector pSG5 was from
Stratagen. Probasin-Luc is a plasmid that contains the firefly
luciferase reporter linked to the herpesvirus thymidine kinase
(tk) promoter and three copies of the rat probasin promoter
fragment (nucleotides −244 to −96) that contains the androgen
responding elements (Jia et al., 2003). The plasmid pMMTV-
Luciferase, which contains 1 copy of the androgen responding
element, has been described before (Nordeen, 1988).
Co-immunoprecipitation experiments
Huh7 cells in a 10-cm Petri dish were transfected with
pCMV-HAX, pSG5-AR and their control expression vectors in
different combinations using the calcium phosphate precipita-
tion method. Forty-eight hours after transfection, cells were
rinsed twice with TBS (10 mM Tris–HCl, pH 7.0, 150 mM
NaCl) and lysed in 1 ml TBS containing 0.5% Nonidet P-40
(NP40). The cell lysates were briefly centrifuged to remove cell
debris. The supernatant was mixed 1:1 with RIPA (10 mM Tris–
HCl, pH 7.0, 150 mM NaCl, 1% Triton X-100, 1% sodium
deoxycholate, 0.1% sodium dodecyl sulfate) and split into two
aliquots. The first aliquot was incubated with 1 μl mouse anti-
HA monoclonal antibody (USC Norris Cancer Center Cell
Culture Core) and the second aliquot was incubated with 1 μl
rabbit anti-AR antibody (Affinity Bioreagents). After incuba-
tion at 4 °C overnight, the immune complex was precipitated
with 20 μl Gammabind Plus (Amersham). The immunopreci-
pitates were washed four times with a 3:1 mixture of RIPA and
the TBS lysis buffer, followed by electrophoresis in an 8–15%
gradient gel. The protein gel was Western blotted to nitro-
cellulose membrane, which was hybridized first with either the
rabbit anti-AR antibody (first aliquot of cell lysates) or the
mouse anti-HA antibody (the second aliquot of cell lysates) and
then with the respective alkaline phosphatase-conjugated goat
anti-mouse or anti-rabbit antibody. The protein bands were
visualized using the BioRad AP color kit (BioRad).
Confocal microscopy
Huh7 cells grown on coverslips in a six-well dish were
transfected with pCMV-HAX, pSG5-AR and their respectivecontrol expression vectors pRc/CMV (Invitrogen) and pSG5 in
different combinations by calcium phosphate precipitation.
Cells were rinsed twice with DMEM without serum on the
second day and further incubated in DMEM with or without
50 nM DHT for 24 h. Cells were fixed with 3.7% formaldehyde
in phosphate-buffered saline (PBS) and then stained with both
the mouse anti-HA and the rabbit anti-AR primary antibodies
and the rhodamine-conjugated goat anti-mouse and fluorescein-
conjugated goat anti-rabbit secondary antibodies for confocal
microscopy.
The luciferase reporter assay
Huh7 cells in six-well dishes were co-transfected with 1.5 μg
Probasin-luc reporter and either 150 ng pSG5-AR or its control
expression vector pSG5. 1.5 μg of pCMV-HAX and its control
vector pRc/CMVin different combinations were also included in
the co-transfection experiment. Cells were incubated in DMEM
containing 0.5% FBS after transfection, treated with 50 nMDHT
or its control solvent ethanol in DMEM on the second day for
24 h and then lysed for the luciferase assay. In all the transfection
experiment, 150 ng pRL-SV40 (Promega), a plasmid that ex-
presses renila luciferase, was used for co-transfection to monitor
the transfection efficiency. The firefly luciferase and the renila
luciferase activities were measured using the dual luciferase
assay (Promega). The firefly luciferase activities were then
normalized against the renila luciferase activities. All the ex-
periments were repeated at least three times.
Chromatin immunoprecipitation (ChIP) assay
2.5–5×105 Huh7 cells in a 6-well dish were transfected with
1.5 μg/well of DNA plasmids with 0.5 μg each of pMMTV-
Luciferase, pCMV-AR and pCMV-HAX. The plasmids pCMV-
AR and pCMV-HAX might be replaced by their control vector
pRc/CMV, depending on the experiments. Eight to twelve hours
after transfection, cells were treated with 10 nM DHT or its
control solvent ethanol for 16–18 h in DMEM that contained
10% charcoal-stripped FBS. Cells were then crosslinked with
1% formaldehyde in PBS at room temperature for 10 min on a
platform shaker. The cross-linking reaction was stopped by
adding glycine to a final concentration of 125 mM with further
shaking at room temperature for 5 min. Cells were then rinsed
three times with ice cold PBS, scraped in 1 ml PBS and pelleted
by centrifugation at 700×g for 4 min. The cell pellet was then
resuspended in the cell lysis buffer (5 mM Pipes, pH 8.0,
85 mM KCl and 0.5% Nonidet-P 40) containing 1 μg/ml
leupeptin, 1 μg/ml aprotinin and 1 mM PMSF and incubated on
ice for 10 min. Nuclei were then pelleted by centrifugation at
5,000 rpm for 5 min in a microcentrifuge and lysed in the
nuclear lysis buffer (50 mM Tris–HCl, pH 8.1, 10 mM EDTA,
1% SDS) containing the same protease inhibitors for 10 min on
ice. The chromosomal DNA was pulse-sonicated on ice to an
average length of 600 bp. The nuclear debris was removed by
centrifugation at full-speed in a microfuge for 10 min at 4 °C.
The supernatant was then diluted 5-fold in the ChIP dilution
buffer (16.7 mM Tris–HCl, pH 8.1, 167 mM NaCl, 1.2 mM
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protease inhibitors. The sample was then pre-treated for 30 min
at 4 °C with 80 μl 50% slurry of protein A-agarose that had been
pretreated with salmon sperm DNA. After the removal of the
protein A-agarose by a brief centrifugation, an aliquot of the
supernatant was saved to serve as the input DNA control, and
the anti-AR antibody NH27 (Wang et al., 1994), the anti-HA
antibody (USC Cell Culture Core Facility) or a control IgG
(Santa Cruz) was added to the rest of the supernatant. After the
incubation at 4 °C overnight with shaking, the sample was
treated at 4 °C for 1 h with 60 μl protein A-agarose slurry that
had been pretreated with salmon sperm DNA. The agarose
beads were then precipitated by a brief centrifugation in a
microfuge and washed consecutively for 3–5 min with 1 ml
each of the following solutions: low salt wash buffer (20 mM
Tris–HCl, pH 8.1, 150 mM NaCl, 2 mM EDTA, 1% Triton X-
100, 0.1% SDS); high salt wash buffer (20 mM Tris–HCl, pH
8.1, 500 mM NaCl, 2 mM EDTA, 1% Triton X-100, 0.1%
SDS); LiCl wash buffer (10 mM Tris–HCl, pH 8.0, 0.25 M
LiCl, 1 mM EDTA, 1% NP40, 1% Na deoxycholate); and TE
(10 mM Tris–HCl, pH 8.0, 1 mM EDTA) twice. The pellet was
then vortex in 250 μl elution buffer (0.1 M NaHCO3, 1% SDS)
for 15 min, pelleted again at 15,000×g for 3 min. The super-
natant was transferred to a new tube. The wash of the pellet was
repeated one more time and the two supernatants were
combined. The formaldehyde cross-linking was reversed by
adding 1 μl 10 mg/ml RNase and 5 M NaCl to a final con-
centration of 0.3 M followed by incubation at 65 °C water bath
for 4–5 h. The DNAwas precipitated with 2.5 volumes of 100%
ethanol at −20 °C overnight and resuspended in 100 μl water.
The input DNA aliquot was treated with the same procedures
followed by the addition of 2 μl 0.5 M EDTA, 4 μl 1 M Tris–
HCl, pH 6.5 and 1 μl 20 mg/ml proteinase K and further
incubated at 45 °C for 1–2 h. The DNAwas then purified using
the QiaQuick spin column (Qiagen) and eluted in 50 μl 10 mM
Tris–HCl, pH 8.0. Two microliters of the DNA was then used
for PCR using the following primers: GGTTCCCAGGGCT-
TAAGTAAG (sense) and GGACCCTCTGGAAAGTGAAG
(antisense). The PCR was conducted using the following
conditions: 94 °C 4 min; 94 °C 45 s, 58 °C 45 s and 72 °C 1 min
for 35 cycles; 72 °C 7 min. The PCR products were then
analyzed on an agarose gel. The experiments were repeated at
least three times to ensure the accuracy of the results.
Acknowledgments
We wish to thank Dr. Ben Yen for critical reading of this
manuscript and Dr. Gerry Coetzee for providing us with the
probasin-luc reporter DNA plasmid. This research was sup-
ported by grants from the National Institutes of Health to CC
and JHJO.
References
Becker, S.A., Lee, T.H., Butel, J.S., Slagle, B.L., 1998. Hepatitis B virus X
protein interferes with cellular DNA repair. J. Virol. 72 (1), 266–272.
Beilin, J., Ball, E.M., Favaloro, J.M., Zajac, J.D., 2000. Effect of theandrogen receptor CAG repeat polymorphism on transcriptional activity:
specificity in prostate and non-prostate cell lines. J. Mol. Endocrinol. 25
(1), 85–96.
Bouchard, M.J., Wang, L.H., Schneider, R.J., 2001. Calcium signaling by HBx
protein in hepatitis B virus DNA replication. Science 294 (5550), 2376–2378.
Bouchard, M.J., Wang, L., Schneider, R.J., 2006. Activation of focal adhesion
kinase by hepatitis B virus HBx protein: multiple functions in viral rep-
lication. J. Virol. 80 (9), 4406–4414.
Chamberlain, N.L., Driver, E.D., Miesfeld, R.L., 1994. The length and location
of CAG trinucleotide repeats in the androgen receptor N-terminal domain
affect transactivation function. Nucleic Acids Res. 22 (15), 3181–3186.
Chatterjee, B., Song, C.S., Jung, M.H., Chen, S., Walter, C.A., Herbert, D.C.,
Weaker, F.J., Mancini, M.A., Roy, A.K., 1996. Targeted overexpression of
androgen receptor with a liver-specific promoter in transgenic mice. Proc.
Natl. Acad. Sci. U.S.A. 93 (2), 728–733.
Chen, H.S., Kaneko, S., Girones, R., Anderson, R.W., Hornbuckle, W.E.,
Tennant, B.C., Cote, P.J., Gerin, J.L., Purcell, R.H., Miller, R.H., 1993. The
woodchuck hepatitis virus X gene is important for establishment of virus
infection in woodchucks. J. Virol. 67 (3), 1218–1226.
Chen, C.H., Huang, G.T., Yang, P.M., Chen, P.J., Lai, M.Y., Chen, D.S., Wang,
J.D., Sheu, J.C., 2006. Hepatitis B- and C-related hepatocellular carcinomas
yield different clinical features and prognosis. Eur. J. Cancer 42 (15),
2524–2529.
Cheong, J.H., Yi, M., Lin, Y., Murakami, S., 1995. Human RPB5, a subunit
shared by eukaryotic nuclear RNA polymerases, binds human hepatitis B
virus X protein and may play a role in X transactivation. EMBO J. 14 (1),
143–150.
Fischer, M., Runkel, L., Schaller, H., 1995. HBx protein of hepatitis B virus
interacts with the C-terminal portion of a novel human proteasome alpha-
subunit. Virus Genes 10 (1), 99–102.
Hu, Z., Zhang, Z., Kim, J.W., Huang, Y., Liang, T.J., 2006. Altered proteolysis
and global gene expression in hepatitis B virus X transgenic mouse liver.
J. Virol. 80 (3), 1405–1413.
Irvine, R.A., Ma, H., Yu, M.C., Ross, R.K., Stallcup, M.R., Coetzee, G.A.,
2000. Inhibition of p160-mediated coactivation with increasing androgen
receptor polyglutamine length. Hum. Mol. Genet. 9 (2), 267–274.
Jia, L., Kim, J., Shen, H., Clark, P.E., Tilley, W.D., Coetzee, G.A., 2003.
Androgen receptor activity at the prostate specific antigen locus: steroidal
and non-steroidal mechanisms. Mol. Cancer Res. 1 (5), 385–392.
Kang, H.Y., Huang, K.E., Chang, S.Y., Ma, W.L., Lin, W.J., Chang, C., 2002.
Differential modulation of androgen receptor-mediated transactivation by
Smad3 and tumor suppressor Smad4. J. Biol. Chem. 277 (46), 43749–43756.
Kirk, G.D., Lesi, O.A., Mendy, M., Akano, A.O., Sam, O., Goedert, J.J.,
Hainaut, P., Hall, A.J., Whittle, H., Montesano, R., 2004. The Gambia Liver
Cancer Study: infection with hepatitis B and C and the risk of hepatocellular
carcinoma in West Africa. Hepatology 39 (1), 211–219.
Klein, N.P., Schneider, R.J., 1997. Activation of Src family kinases by hepatitis
B virus HBx protein and coupled signaling to Ras. Mol. Cell. Biol. 17 (11),
6427–6436.
Lee, H.J., Chang, C., 2003. Recent advances in androgen receptor action. Cell
Mol. Life Sci. 60 (8), 1613–1622.
Li, J., Xu, Z., Zheng, Y., Johnson, D.L., Ou, J.H., 2002. Regulation of
hepatocyte nuclear factor 1 activity by wild-type and mutant hepatitis B
virus X proteins. J. Virol. 76 (12), 5875–5881.
Litvinov, I.V., Chang, C., Isaacs, J.T., 2004. Molecular characterization of the
commonly used human androgen receptor expression vector, pSG5-AR.
Prostate 58 (4), 319–324.
Lu, S.N., Su, W.W., Yang, S.S., Chang, T.T., Cheng, K.S., Wu, J.C., Lin, H.H.,
Wu, S.S., Lee, C.M., Changchien, C.S., Chen, C.J., Sheu, J.C., Chen, D.S.,
Chen, C.H., 2006. Secular trends and geographic variations of hepatitis B
virus and hepatitis C virus-associated hepatocellular carcinoma in Taiwan.
Int. J. Cancer 119 (8), 1946–1952.
Maguire, H.F., Hoeffler, J.P., Siddiqui, A., 1991. HBV X protein alters the DNA
binding specificity of CREB and ATF-2 by protein–protein interactions.
Science 252 (5007), 842–844.
Nordeen, S.K., 1988. Luciferase reporter gene vectors for analysis of promoters
and enhancers. BioTechniques 6 (5), 454–458.
Rahmani, Z., Huh, K.W., Lasher, R., Siddiqui, A., 2000. Hepatitis B virus X
461Y. Zheng et al. / Virology 363 (2007) 454–461protein colocalizes to mitochondria with a human voltage-dependent anion
channel, HVDAC3, and alters its transmembrane potential. J. Virol. 74 (6),
2840–2846.
Seto, E., Mitchell, P.J., Yen, T.S., 1990. Transactivation by the hepatitis B virus
X protein depends on AP-2 and other transcription factors. Nature 344
(6261), 72–74.
Stroffolini, T., Sagnelli, E., Mariano, A., Craxi, A., Almasio, P., 2006.
Characteristics of HCV positive subjects referring to hospitals in Italy: a
multicentre prevalence study on 6,999 cases. J. Viral Hepat. 13 (5), 351–354.
Su, F., Theodosis, C.N., Schneider, R.J., 2001. Role of NF-kappaB and myc
proteins in apoptosis induced by hepatitis B virus HBx protein. J. Virol. 75
(1), 215–225.
Tanaka, K., Sakai, H., Hashizume, M., Hirohata, T., 2000. Serum testosterone:
estradiol ratio and the development of hepatocellular carcinoma among
male cirrhotic patients. Cancer Res. 60 (18), 5106–5110.
Tomura, A., Goto, K., Morinaga, H., Nomura, M., Okabe, T., Yanase, T.,
Takayanagi, R., Nawata, H., 2001. The subnuclear three-dimensional image
analysis of androgen receptor fused to green fluorescence protein. J. Biol.
Chem. 276 (30), 28395–28401.
Touraine, R.L., Bertrand, Y., Foray, P., Gilly, J., Philippe, N., 1993. Hepatic
tumours during androgen therapy in Fanconi anaemia. Eur. J. Pediatr. 152
(8), 691–693.
Wang, X.W., Forrester, K., Yeh, H., Feitelson, M.A., Gu, J.R., Harris, C.C.,
1994. Hepatitis B virus X protein inhibits p53 sequence-specific DNA
binding, transcriptional activity, and association with transcription factor
ERCC3. Proc. Natl. Acad. Sci. U.S.A. 91 (6), 2230–2244.
Williams, J.S., Andrisani, O.M., 1995. The hepatitis B virus X protein targets thebasic region-leucine zipper domain of CREB. Proc. Natl. Acad. Sci. U.S.A.
92 (9), 3819–3823.
Xie, X., Zhao, X., Liu, Y., Young, C.Y., Tindall, D.J., Slawin, K.M., Spencer, D.
M., 2001. Robust prostate-specific expression for targeted gene therapy
based on the human kallikrein 2 promoter. Hum.Gene Ther. 12 (5), 549–561.
Xu, Z., Yen, T.S., Wu, L., Madden, C.R., Tan, W., Slagle, B.L., Ou, J.H., 2002.
Enhancement of hepatitis B virus replication by its X protein in transgenic
mice. J. Virol. 76 (5), 2579–2584.
Yen, T.S., 1996. Hepadnaviral X protein: review of recent progress. J. Biomed.
Sci. 3 (1), 20–30.
Yoon, G., Kim, J.Y., Choi, Y.K., Won, Y.S., Lim, I.K., 2006. Direct activation of
TGF-beta1 transcription by androgen and androgen receptor complex in
Huh7 human hepatoma cells and its tumor in nude mice. J. Cell Biochem. 97
(2), 393–411.
Yu, M.W., Cheng, S.W., Lin, M.W., Yang, S.Y., Liaw, Y.F., Chang, H.C., Hsiao,
T.J., Lin, S.M., Lee, S.D., Chen, P.J., Liu, C.J., Chen, C.J., 2000. Androgen-
receptor gene CAG repeats, plasma testosterone levels, and risk of hepatitis
B-related hepatocellular carcinoma. J. Natl. Cancer Inst. 92 (24), 2023–2028.
Yu, M.W., Yang, Y.C., Yang, S.Y., Cheng, S.W., Liaw, Y.F., Lin, S.M., Chen,
C.J., 2001. Hormonal markers and hepatitis B virus-related hepatocellular
carcinoma risk: a nested case–control study among men. J. Natl. Cancer Inst.
93 (21), 1644–1651.
Zhang, Z., Torii, N., Hu, Z., Jacob, J., Liang, T.J., 2001. X-deficient woodchuck
hepatitis virus mutants behave like attenuated viruses and induce protective
immunity in vivo. J. Clin. Invest. 108 (10), 1523–1531.
Zoulim, F., Saputelli, J., Seeger, C., 1994. Woodchuck hepatitis virus X protein
is required for viral infection in vivo. J. Virol. 68 (3), 2026–2030.
